Efforts to advance chronic disease prevention through enhanced education, awareness and support — kicking off during National Kidney Month DENVER, March 11, 2024 /PRNewswire/ — Today, The American Diabetes Association ® (ADA) and DaVita (NYSE: DVA), a leading provider of kidney care…
Month: March 2024
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980 The…
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980 The…
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Luminar Technologies, Inc. (“Luminar” or the “Company”) (NASDAQ: LAZR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Luminar Technologies, Inc. (“Luminar” or the “Company”) (NASDAQ: LAZR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
SHENZHEN, Čína, 11. marca 2024 /PRNewswire/ — Spoločnosť Huawei oznámila, že bola vymenovaná za lídra v rebríčku Gartner® Magic Quadrant™ 2024 pre infraštruktúru podnikových káblových a bezdrôtových sietí LAN, ako jediný predajca mimo Severnej Ameriky, ktorý sa umiestnil v kvadrante…
SHENZHEN, Čína, 11. marca 2024 /PRNewswire/ — Spoločnosť Huawei oznámila, že bola vymenovaná za lídra v rebríčku Gartner® Magic Quadrant™ 2024 pre infraštruktúru podnikových káblových a bezdrôtových sietí LAN, ako jediný predajca mimo Severnej Ameriky, ktorý sa umiestnil v kvadrante…
Submission is supported by data from the Phase 3 QUASAR program, which showed a significantly greater percentage of patients with moderately to severely active ulcerative colitis who received TREMFYA® achieved clinical remission at Week 44 compared with placebo SPRING HOUSE, Pa., March…
Submission is supported by data from the Phase 3 QUASAR program, which showed a significantly greater percentage of patients with moderately to severely active ulcerative colitis who received TREMFYA® achieved clinical remission at Week 44 compared with placebo SPRING HOUSE, Pa., March…
NEW YORK, March 11, 2024 /PRNewswire/ — Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that an aggregate of $50,000 has been deposited into the Company’s trust account to further extend the period of time the Company has to consummate its business…